Ā | Baseline T1 | 3 months T2 | 6 months T3 | Test-statistic (T2-T1, T3-T1) |
---|---|---|---|---|
Number of participants with UI | ||||
Intervention group | 40 | 37 | 40 | 0.66 (0.15,2.90), 0.80 (0.34,1.88) |
Control group | 40 | 38 | 34 | |
Frequency incontinence episodes (Number/ 3 days); mean (sd) | ||||
Intervention group | 8.0 (11.0) | 6.6 (9.1) | 9.0 (11.4) | ā1.71 (ā5.99,2.56), 1.38 (ā3.03,5.79) |
Control group | 9.5 (11.5) | 7.4 (10.1) | 7.1 (9.6) | |
Physical Performance Test (0-28ā ); mean (sd) | ||||
Intervention group | 17.2 (4.87) | Ā | 18.5 (4 14) | 3.21 (1.81,4.62), pā<ā0.001 |
Control group | 15.8 (5.16) | Ā | 14.7 (4.27) | |
Health Related Quality of Life SF-12 (mental; 0-100); mean (sd) | ||||
Intervention group | 47.0 (14.2) | Ā | 52.0 (10.0) | 0.07 (ā4.24,4.39) |
Control group | 46.0 (12.8) | Ā | 51.3 (8.5) | |
Health Related Quality of Life SF-12 (physical; 0-100ā ); mean (sd) | ||||
Intervention group | 34.7 (12.0) | Ā | 38.3 (11.6) | 1.70 (ā3.39,6.80) |
Control group | 34.1 (10.1) | Ā | 35.0 (12.1) | |
Specific Quality of Life (I-QOL; 0-110ā ); mean (sd) | ||||
Intervention group | 68.9 (17.9) | Ā | 65.7 (15.6) | ā3.30 (ā10.2,3.63) |
Control group | 62.2 (17.7) | Ā | 66.2 (15.6) |